Hint mode is switched on Switch off
For swift navigation between sections

Oculis Holding
LEI 5067005370C2KK324336

Organization name
Oculis Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Oculis Holding AG operates as a biopharmaceutical company. The Company provides eye care treatments for ophthalmology such as retina, dry eye, and neuro ophtha diseases. Oculis Holding serves patients worldwide.

Awards

Documentation

IFRS/US GAAP reports

2025
2024
2023
2022
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    5067005370C2KK324336
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001953530
  • UID
    CHE396695611
Registration is required to get access.